debt restructuring

TORONTO | January 5, 2026 — PharmaDrug Inc. has completed the acquisition of an initial 19.9% equity interest in...

Toronto, Ontario – October 31, 2025 — PharmaDrug Inc. (CSE: PHRX; OTC Pink: LMLLF), a specialty pharmaceutical company focused...